These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37808185)

  • 1. Editorial: Natural products in the treatment of neurological diseases: identification of novel active compounds and therapeutic targets.
    Zhao J; Wang D; Cui W; Chen H
    Front Pharmacol; 2023; 14():1294625. PubMed ID: 37808185
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Novel therapeutic target and drug discovery for neurological diseases.
    Zhao K; Li Z; Liu Q; Cheng Y; Barreto GE; Liu R
    Front Pharmacol; 2022; 13():1042266. PubMed ID: 36278216
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.
    Küpeli Akkol E; Tatlı Çankaya I; Şeker Karatoprak G; Carpar E; Sobarzo-Sánchez E; Capasso R
    Front Pharmacol; 2021; 12():669638. PubMed ID: 34054540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel drug targets and their functions using phenotypic screening of natural products.
    Chang J; Kwon HJ
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):221-31. PubMed ID: 26364198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating Epilepsy with Natural Products: Nonsense or Possibility?
    Malaník M; Čulenová M; Sychrová A; Skiba A; Skalicka-Woźniak K; Šmejkal K
    Pharmaceuticals (Basel); 2023 Jul; 16(8):. PubMed ID: 37630977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Targets for the Treatment of Comorbidities Associated with Epilepsy.
    Gangar K; Bhatt LK
    Curr Mol Pharmacol; 2020; 13(2):85-93. PubMed ID: 31793425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms.
    Choi DY; Choi H
    Arch Pharm Res; 2015 Feb; 38(2):139-70. PubMed ID: 25348867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke.
    Li XH; Yin FT; Zhou XH; Zhang AH; Sun H; Yan GL; Wang XJ
    Molecules; 2022 May; 27(10):. PubMed ID: 35630576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Products for the Treatment of Post-stroke Depression.
    Fang C; Zhang Z; Xu H; Liu Y; Wang X; Yuan L; Xu Y; Zhu Z; Zhang A; Shao A; Lou M
    Front Pharmacol; 2022; 13():918531. PubMed ID: 35712727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Predictors of Depression Among Patients With Epilepsy, Stroke, and Multiple Sclerosis Using the Cleveland Clinic Knowledge Program Within the Neurological Institute.
    Viguera AC; Fan Y; Thompson NR; Lapin B; Chaitoff A; Griffith SD; Miller DM; Jehi L; Katzan IL
    Psychosomatics; 2018; 59(4):369-378. PubMed ID: 29580558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural or Plant Products for the Treatment of Neurological Disorders: Current Knowledge.
    Parvez MK
    Curr Drug Metab; 2018; 19(5):424-428. PubMed ID: 28699506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural products for the treatment of stress-induced depression: Pharmacology, mechanism and traditional use.
    Dai W; Feng K; Sun X; Xu L; Wu S; Rahmand K; Jia D; Han T
    J Ethnopharmacol; 2022 Mar; 285():114692. PubMed ID: 34742864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of DAPK1 by Natural Products: An Important Target in Treatment of Stroke.
    Noori T; Shirooie S; Sureda A; Sobarzo-Sanchez E; Dehpour AR; Saldías M; Akkol EK
    Neurochem Res; 2022 Aug; 47(8):2142-2157. PubMed ID: 35674928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential of Active Components from
    Kim CJ; Kwak TY; Bae MH; Shin HK; Choi BT
    J Pharmacopuncture; 2022 Dec; 25(4):326-343. PubMed ID: 36628348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Opportunities and Challenges for Drug Discovery From Natural Products in Pharmacotherapy of Neurological Disorders.
    Jeandet P; Kumar V; Tewari D
    Front Neurosci; 2022; 16():936981. PubMed ID: 35712459
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroprotective Strategies for Neurological Disorders by Natural Products: An update.
    Rehman MU; Wali AF; Ahmad A; Shakeel S; Rasool S; Ali R; Rashid SM; Madkhali H; Ganaie MA; Khan R
    Curr Neuropharmacol; 2019; 17(3):247-267. PubMed ID: 30207234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New opportunities and challenges of natural products research: When target identification meets single-cell multiomics.
    Zhu Y; Ouyang Z; Du H; Wang M; Wang J; Sun H; Kong L; Xu Q; Ma H; Sun Y
    Acta Pharm Sin B; 2022 Nov; 12(11):4011-4039. PubMed ID: 36386472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy.
    Gangisetty O; Murugan S
    Adv Neurobiol; 2016; 12():1-25. PubMed ID: 27651245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma.
    Chaurasiya ND; Leon F; Muhammad I; Tekwani BL
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.